Last updated on December 2019

A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis


Brief description of study

The purpose of this study is to evaluate the clinical efficacy and safety of combination therapy with guselkumab and golimumab in participants with moderately to severely active ulcerative colitis (UC).

Clinical Study Identifier: NCT03662542

Find a site near you

Start Over

Royal Melbourne Hospital

Parkville, Australia
1.71miles
  Connect »